Liquidia (LQDA) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Liquidia (LQDA) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Liquidia | 6.36 Bn | 6.08 Bn | 160.92 Mn | 304.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 126.75% |
| Mar 31, 2026 | 157.46% |
| Dec 31, 2025 | 135.80% |
| Sep 30, 2025 | 101.89% |
| Jun 30, 2025 | -36.91% |
| Mar 31, 2025 | -31.14% |
| Dec 31, 2024 | 40.54% |
| Sep 30, 2024 | 29.71% |
| Jun 30, 2024 | 45.77% |
| Mar 31, 2024 | 25.51% |
| Dec 31, 2023 | -246.21% |
| Sep 30, 2023 | -7.18% |
| Jun 30, 2023 | 55.20% |
| Mar 31, 2023 | 96.19% |
| Dec 31, 2022 | 109.25% |
| Sep 30, 2022 | 23.76% |
| Jun 30, 2022 | 58.17% |
| Mar 31, 2022 | -761.39% |
| Dec 31, 2021 | -2.93% |
| Sep 30, 2021 | 98.63% |